Jakarta, 21/1/2022 (ANTARA) -
The Indonesian Government has expedited the implementation of the
vaccination drive, including booster shot offers, following the
surfacing of the new COVID-19 variant called Omicron that has spread in
Optimizing the vaccination campaign has become increasingly urgent, as the nation has reported a nearly fivefold increase in the number of COVID-19 cases in the past three weeks, according to the COVID-19 Handling Task Force.
The number of COVID-19 cases had increased, from 1,123 to 5,454 in the past three weeks, spokesperson for the COVID-19 Handling Task Force, Wiku Adisasmito, stated on January 20, 2022.
The number of active COVID-19 cases this week reached 8,605, an increase of three thousand as compared to the previous week when the number of cases totalled 5,494. The spread of COVID-19 in Indonesia is mostly due to local transmission.
The first case of COVID-19 was confirmed in Indonesia in March 2020. As of January 20, 2022, at least 4,277,644 people had tested positive for COVID-19 in the country, while 4,121,117 people had recovered, and 144,199 people had succumbed to the virus.
The Health Ministry detected the first Omicron case in Indonesia on December 15, 2021. As of January 20, 2022, the ministry has recorded as many as 882 Omicron cases in the country.
Based on data from the COVID-19 Task Force, as of January 20, a total of 179,153,744 Indonesians had received the first dose of the COVID-19 vaccine and 122,378,266 people had received the second dose.
Overall, the government is targeting to fully vaccinate 208,265,720 Indonesians out of the nations population of over 273 million.
In addition, 1,328,659, or 90.46 percent of the health workers have been administered the booster vaccine.
The Indonesian government, on January 12, 2022, rolled out booster vaccinations for the public, in general, who have completed six months since having received the second COVID-19 dose.
Booster vaccinations, which are free and not mandatory, aim to offer additional protection to individuals amid the emergence of the Omicron strain.